Latest information re obtaining treatment abroad
LATEST INFORMATION ON OBTAINING
TREATMENT IN EU for UK patients
2. The proposed Directive relates specifically to patients being able to choose where they go for treatment. Patients will need to pay up-front and are later reimbursed by their home country (national health insurer or health authority) as long as they have a right to this treatment at home, and up to the level of reimbursement for the same or similar treatment in their national health system.
3. In other words, the Directive is about giving patients more choice on where they get the treatment.
4. If patients can’t get treatment on their National Health System because the waiting list is too long or the treatment does not exisist then it is up to the National Health System of the country to provide prior authorisation to the patient. This will then enable the patient to travel for treatment and they will not need to pay up front.
This refers to another law that is already in force – the EU regulation on coordination of social security. The case of Avene that you mention might come under this Regulation if patients were sent there by their heath authority without having to pay up front.
More info on http://ec.europa.eu/health-eu/doc/crossborder_brochure_en.pdf
or http://ec.europa.eu/employment_social/social_security_schemes/healthcare/e112/conditions_en.htm
and good luck – you need a wet cloth and headache pills to understand these sites!
The Regulation on coordiantion of social security and can be accessed here:
http://ec.europa.eu/employment_social/social_security_schemes/healthcare/index_en.htm
and also check up-to-date information on www.after-cancer.com/treatmentineurope

![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=f35a5dc2-37b2-4318-8c02-b7e6e949470c)





















































